| The IFN-gamma-CXCL9/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment. | The IFN-γ-CXCL9/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment.
Liu H, Wang Y, Le Q, Tong J, Wang H. | 04/17/2024 |
| Hyperactivation of beta-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis. | Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
Wang K, Wu J, Yang Z, Zheng B, Shen S, Wang RR, Zhang Y, Wang HY, Chen L, Qiu X. | 03/19/2024 |
| The CXCL10-CXCR3 axis plays an important role in Kawasaki disease. | The CXCL10-CXCR3 axis plays an important role in Kawasaki disease.
Hosaka S, Imagawa K, Yano Y, Lin L, Shiono J, Takahashi-Igari M, Hara H, Hayashi D, Imai H, Morita A, Fukushima H, Takada H., | 03/13/2024 |
| CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients. | CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients.
Shamsi A, Roghani SA, Abdan Z, Soufivand P, Pournazari M, Bahrehmand F, Vafaei A, Salari N, Soroush MG, Taghadosi M. | 11/30/2023 |
| Role of CXCR3 in fibrotic tissue responses. | Role of CXCR3 in fibrotic tissue responses.
Wells A. | 11/15/2023 |
| IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways. | IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways.
Liu L, Cheng Y, Zhang F, Chen J, Tian P, Shi W, Zhou F, Yang M, Zhou M, Liu B. | 07/27/2023 |
| EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3. | EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3.
Higuchi T, Hashida Y, Matsuo K, Kitahata K, Ujihara T, Murakami I, Nakayama T, Daibata M., Free PMC Article | 06/7/2023 |
| Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate. | Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate.
Burrack AL, Spartz EJ, Rollins MR, Miller EA, Firulyova M, Cruz E, Goldberg MF, Wang IX, Nanda H, Shen S, Zaitsev K, Stromnes IM., Free PMC Article | 05/30/2023 |
| Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients. | Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients.
Alfaro R, Llorente S, Gonzalez-Martínez G, Jimenez-Coll V, Martínez-Banaclocha H, Galián JA, Botella C, Moya-Quiles MR, de la Peña-Moral J, Minguela A, Legaz I, Muro M. | 03/15/2023 |
| Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma. | Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.
Takashima Y, Hamano M, Yoshii K, Hayano A, Fukai J, Iwadate Y, Kajiwara K, Hondoh H, Yamanaka R. | 03/8/2023 |
| CXCR3 predicts the prognosis of endometrial adenocarcinoma. | CXCR3 predicts the prognosis of endometrial adenocarcinoma.
Dong H, Sun M, Li H, Yue Y., Free PMC Article | 02/13/2023 |
| Relationship between dry eye and expressions of CXCR3 and CCR5 after ocular acid burn. | Relationship between dry eye and expressions of CXCR3 and CCR5 after ocular acid burn.
Jiang B, Hu Q, Li T, She M, Li C, Zhou X., Free PMC Article | 12/24/2022 |
| CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance. | CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
Sun WH, Peng TJ, Tang SJ, Lin JY, Wang CY, Fang HJ, Sun KH. | 10/22/2022 |
| Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers. | Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.
Liisborg C, Skov V, Kjær L, Hasselbalch HC, Lykke Sørensen T., Free PMC Article | 06/25/2022 |
| Chemokine receptor CXCR3 is required for lethal brain pathology but not pathogen clearance during cryptococcal meningoencephalitis. | Chemokine receptor CXCR3 is required for lethal brain pathology but not pathogen clearance during cryptococcal meningoencephalitis.
Xu J, Neal LM, Ganguly A, Kolbe JL, Hargarten JC, Elsegeiny W, Hollingsworth C, He X, Ivey M, Lopez R, Zhao J, Segal B, Williamson PR, Olszewski MA., Free PMC Article | 04/23/2022 |
| TNF-alpha augments CXCL10/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell. | TNF-α augments CXCL10/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell.
Wang Z, Ao X, Shen Z, Ao L, Wu X, Pu C, Guo W, Xing W, He M, Yuan H, Yu J, Li L, Xu X., Free PMC Article | 03/19/2022 |
| Cxcl10 Chemokine Induces Migration of ING4-Deficient Breast Cancer Cells via a Novel Cross Talk Mechanism between the Cxcr3 and Egfr Receptors. | Cxcl10 Chemokine Induces Migration of ING4-Deficient Breast Cancer Cells via a Novel Cross Talk Mechanism between the Cxcr3 and Egfr Receptors.
Tsutsumi E, Stricklin J, Peterson EA, Schroeder JA, Kim S., Free PMC Article | 03/5/2022 |
| Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation. | Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation.
Gauthier M, Kale SL, Oriss TB, Scholl K, Das S, Yuan H, Hu S, Chen J, Camiolo M, Ray P, Wenzel S, Ray A., Free PMC Article | 03/5/2022 |
| Increased Activation of Innate Immunity and Pro-Apoptotic CXCR3B in Normal-Appearing Skin on the Lesional Site of Patients with Segmental Vitiligo. | Increased Activation of Innate Immunity and Pro-Apoptotic CXCR3B in Normal-Appearing Skin on the Lesional Site of Patients with Segmental Vitiligo.
Passeron T, Malmqvst VEA, Bzioueche H, Marchetti S, Rocchi S, Tulic MK. | 02/5/2022 |
| GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models. | GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.
Torphy RJ, Sun Y, Lin R, Caffrey-Carr A, Fujiwara Y, Ho F, Miller EN, McCarter MD, Lyons TR, Schulick RD, Kedl RM, Zhu Y., Free PMC Article | 01/29/2022 |
| Role of the CXCR3mediated TLRs/MyD88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer. | Role of the CXCR3‑mediated TLRs/MyD88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer.
Yuan G, Chen B, Meng Y, Lu J, Shi X, Hu A, Hu Y, Wang D., Free PMC Article | 01/8/2022 |
| A Regulatory Role of Chemokine Receptor CXCR3 in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Emphysema. | A Regulatory Role of Chemokine Receptor CXCR3 in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Emphysema.
Li L, Liu Y, Chiu C, Jin Y, Zhou W, Peng M, Chen LC, Sun Q, Gao J. | 12/11/2021 |
| Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma. | Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.
Middleton MR, McAlpine C, Woodcock VK, Corrie P, Infante JR, Steven NM, Evans TRJ, Anthoney A, Shoushtari AN, Hamid O, Gupta A, Vardeu A, Leach E, Naidoo R, Stanhope S, Lewis S, Hurst J, O'Kelly I, Sznol M., Free PMC Article | 11/27/2021 |
| CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma. | CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma.
Cannon A, Thompson CM, Maurer HC, Atri P, Bhatia R, West S, Ghersi D, Olive KP, Kumar S, Batra SK., Free PMC Article | 11/27/2021 |
| Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab. | Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab.
Iwai T, Sugimoto M, Patil NS, Bower D, Suzuki M, Kato C, Yorozu K, Kurasawa M, Shames DS, Kondoh O., Free PMC Article | 11/6/2021 |